rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael R. McDonnell

Director

Company insider

Files Form 4 as: Director, Moderna; Director, Merit Medical Systems; Director, Baxter International; EVP, Chief Financial Officer, Biogen; EVP and CFO, IQVIA Holdings; Director, Frontier Communications; EVP and CFO, IMS Health Holdings; Director, Catalyst Health Solutions.

In numbers

Trades disclosed
123
Buys
0
Sells
8
Bought
$0
Sold
$4.4M
Companies
9
Companies where not an officer
5
First trade
6 Jun 2006
Last trade
8 Jul 2026
Last filed
10 Jul 2026

Companies traded

Where they are an officer
BIIB BiogenOfficer · Biotechnology · last 10 Feb 20250 buys · 0 sells
IQV IQVIA HoldingsOfficer · Life-science tools · last 5 Jul 20200 buys · 2 sells
IMS Health HoldingsOfficer · last 5 Jul 20170 buys · 0 sells
Mcg CapitalOfficer · last 30 Apr 20080 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MRNA ModernaDirector · Biotechnology · last 8 Jul 20260 buys · 0 sells
MMSI Merit Medical SystemsDirector · Medical Devices · last 18 May 20260 buys · 2 sells
BAX Baxter InternationalDirector · Medical Devices · last 5 May 20260 buys · 0 sells
Frontier CommunicationsDirector · last 1 Apr 20190 buys · 0 sells
Catalyst Health SolutionsDirector · last 2 Jul 20120 buys · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jul 2026filed 10 Jul 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—7,415 at $0.00filing
8 Jul 2026filed 10 Jul 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—1,618 at $0.00filing
8 Jul 2026filed 10 Jul 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—5,733 at $0.00filing
8 Jul 2026filed 10 Jul 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—7,415 at $0.00filing
8 Jul 2026filed 10 Jul 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—1,618 at $0.00filing
8 Jul 2026filed 10 Jul 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—5,733 at $0.00filing
18 May 2026filed 19 May 2026MMSI Merit Medical SystemsMedical DevicesSEC FORM 4 Code A—3,457 at $0.00filing
18 May 2026filed 19 May 2026MMSI Merit Medical SystemsMedical DevicesSEC FORM 4 Code A—3,457 at $0.00filing
5 May 2026filed 7 May 2026BAX Baxter InternationalMedical DevicesSEC FORM 4 Code A—12,836 at $0.00filing
5 May 2026filed 7 May 2026BAX Baxter InternationalMedical DevicesSEC FORM 4 Code A—12,836 at $0.00filing
13 Feb 2026filed 18 Feb 2026BAX Baxter InternationalMedical DevicesSEC FORM 4 Code A—1,811 at $0.00filing
13 Feb 2026filed 18 Feb 2026BAX Baxter InternationalMedical DevicesSEC FORM 4 Code A—1,811 at $0.00filing
2 Jun 2025filed 3 Jun 2025MMSI Merit Medical SystemsMedical DevicesSEC FORM 4 Sold$165K1,750 at $94.51filing
30 May 2025filed 3 Jun 2025MMSI Merit Medical SystemsMedical DevicesSEC FORM 4 Sold$165K1,750 at $94.30filing
15 May 2025filed 19 May 2025MMSI Merit Medical SystemsMedical DevicesSEC FORM 4 Code A—2,152 at $0.00filing
10 Feb 2025filed 12 Feb 2025BIIB Biogenoption or derivative · BiotechnologySEC FORM 4 Code M—3,257 at $0.00filing
10 Feb 2025filed 12 Feb 2025BIIB BiogenBiotechnologySEC FORM 4 Code M—3,257 at $0.00filing
10 Feb 2025filed 12 Feb 2025BIIB BiogenBiotechnologySEC FORM 4 Code F$195K1,371 at $142.54filing
7 Feb 2025filed 10 Feb 2025BIIB Biogenoption or derivative · BiotechnologySEC FORM 4 Code M—2,335 at $0.00filing
7 Feb 2025filed 10 Feb 2025BIIB Biogenoption or derivative · BiotechnologySEC FORM 4 Code M—2,216 at $0.00filing

News

IQVIA (NYSE:IQV) Given New $303.00 Price Target at Stifel NicolausIQV · themarketsdaily.com · 14 Oct 2026Reviewing Merit Medical Systems (NASDAQ:MMSI) & STERIS (NYSE:STE)MMSI · tickerreport.com · 13 Oct 2026

0 headlines in the last 90 days name Michael R. McDonnell; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.

Sectors

Health Care4
Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Sean GodboutChief Accounting Officer · Chief Accounting Officer at Biogen, filing Form 4 there in the last year
James G. BerkshireOfficer · Officer at Iqvia Holdings, filing Form 4 there in the last year
Michael PariniChief Legal Officer · Chief Legal Officer at Biogen, filing Form 4 there in the last year
Lloyd MinorDirector · Director at Biogen, filing Form 4 there in the last year
W. Richard StaubOfficer · Officer at Iqvia Holdings, filing Form 4 there in the last year
Kevin HernRepresentative, OK-01 · Also traded IQV in the last 90 days
Neil W. PetersonChief Operating Officer · Also traded MMSI in the last 90 days
Bhavik PatelOfficer · Also traded IQV in the last 90 days